Incidence of precancerous cervical lesions decreasing among young women
the ONA take:
According to a new study published in the journal Cancer, researchers have found that the incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
Cervical intraepithelial neoplasia grade 2, 3, and adenocarcinoma in situ (CIN2+) lesions can be monitored as early indicators of the effect of human papillomavirus (HPV) vaccines.
For the study, researchers identified over 9,000 cases of CIN2+ among patients aged 18 to 39 years in California, Connecticut, New York, and Oregon.
Researchers found that from 2008 to 2012, the rates of CIN2+ significantly decreased among women aged 18 to 20 years in all four states and among 21- to 29-year-old women in Connecticut and New York.
Researchers found that screening rates also declined during that time period, suggesting that the decline in these cervical lesions is most likely due to fewer screenings, but could potentially be an effect of vaccination as well.
Incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|